Q32 Bio Inc. (QTTB) Total Current Liabilities (2017 - 2026)

Q32 Bio has reported Total Current Liabilities for 10 years, with the latest figure at $5.4 million in Q2 2026.

• On a quarterly basis, Total Current Liabilities fell 53.17% year-over-year to $5.4 million in Q2 2026; TTM through Jun 2026 was $5.4 million, a 53.17% decrease from a year earlier, with the FY2025 full-year figure at $11.3 million, down 31.09% from the prior year.
• Total Current Liabilities was $5.4 million for Q2 2026 at Q32 Bio, down from $10.7 million in the prior quarter.
• The five-year high for Total Current Liabilities was $33.0 million in Q1 2024, with the low at $5.4 million in Q2 2026.
• Average Total Current Liabilities over 5 years is $17.5 million, with a median of $16.8 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities jumped 78.06% in 2024, then plunged 55.76% in 2025.
• Over 5 years, Total Current Liabilities stood at $22.6 million in 2022, then plunged by 37.5% to $14.1 million in 2023, then advanced by 16.7% to $16.5 million in 2024, then tumbled by 31.09% to $11.3 million in 2025, then plunged by 52.4% to $5.4 million in 2026.
• The last three Total Current Liabilities figures came in at $5.4 million (Q2 2026), $10.7 million (Q1 2026), and $11.3 million (Q4 2025), per Business Quant data.